TNF, originally identified as a pleiotropic cytokine, mediates innate immunity which is capable of inducing hemorrhagic necrosis of tumors; therefore, the history of this factor is tightly correlated with tumor immunotherapy [35]. The gene discussed is TNF; the disease is neoplasm.